Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-002934)

Filing Details

Accession Number:: 0001415889-24-002934
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-07 16:36:56
Reporting Period:: 2024-02-06

Accepted Time:: 2024-02-07 16:36:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1999480	Alto Neuroscience Inc.	ANRO	Pharmaceutical Preparations (2834)	834210124

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2007795	Amit Etkin	C/O Alto Neuroscience, Inc. 369 South San Antonio Road Los Altos CA 94022	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-02-06	11,777	$0.00	1,202,340	No	4	C	Direct
Common Stock	Acquisiton	2024-02-06	3,125	$16.00	1,205,465	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2024-02-06	25,000	$0.00	11,777	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.